Patents by Inventor Harshal Khanwalkar

Harshal Khanwalkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8822526
    Abstract: A novel pharmaceutical combination comprising a cytotoxic antineoplastic agent selected from a the group consisting of paclitaxel, docetaxel, doxorubicin and gemcitabine or a pharmaceutically acceptable salt thereof and at least one cyclin dependent kinase (CDK) inhibitor; wherein the said combination exhibits synergistic effects when used in the treatment of cancer. The invention also relates to a method for the treatment of cancer, using a therapeutically effective amount of the said combination.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: September 2, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Maggie Rathos, Kalpana Joshi, Harshal Khanwalkar, Somesh Sharma
  • Publication number: 20100305057
    Abstract: A novel pharmaceutical combination comprising a cytotoxic antineoplastic agent selected from a the group consisting of paclitaxel, docetaxel, doxorubicin and gemcitabine or a pharmaceutically acceptable salt thereof and at least one cyclin dependent kinase (CDK) inhibitor; wherein the said combination exhibits synergistic effects when used in the treatment of cancer. The invention also relates to a method for the treatment of cancer, using a therapeutically effective amount of the said combination.
    Type: Application
    Filed: May 15, 2007
    Publication date: December 2, 2010
    Applicant: PIRAMAL LIFE SCIENCES LIMITED
    Inventors: Maggie Rathos, Kalpana Joshi, Harshal Khanwalkar, Somesh Sharma